tiprankstipranks
Advertisement
Advertisement

HK:6855 Stock Latest News

Ascentage Pharma Advances Phase III Oral Combo in CLL: What Investors Should Watch
Company AnnouncementsAscentage Pharma Advances Phase III Oral Combo in CLL: What Investors Should Watch
5d ago
6855
Ascentage Pharma files to sell American Depositary Shares, no amount given
PremiumThe Fly
Ascentage Pharma files to sell American Depositary Shares, no amount given
13d ago
AAPG
Ascentage Pharma Sets Up $200 Million Nasdaq ATM Offering Program
PremiumCompany Announcements
Ascentage Pharma Sets Up $200 Million Nasdaq ATM Offering Program
14d ago
6855
Ascentage Pharma management to meet with B. Riley
PremiumThe Fly
Ascentage Pharma management to meet with B. Riley
17d ago
AAPG
Ascentage Pharma Corrects AGM Date for Share Incentive Scheme Mandate
PremiumCompany Announcements
Ascentage Pharma Corrects AGM Date for Share Incentive Scheme Mandate
21d ago
6855
Ascentage Pharma Grants New RSUs to 453 Employees Under 2021 Scheme
PremiumCompany AnnouncementsAscentage Pharma Grants New RSUs to 453 Employees Under 2021 Scheme
1M ago
6855
Ascentage Pharma assumed with an Outperform at Oppenheimer
Premium
The Fly
Ascentage Pharma assumed with an Outperform at Oppenheimer
2M ago
AAPG
Ascentage Pharma announces clinical updates from EHA2026
Premium
The Fly
Ascentage Pharma announces clinical updates from EHA2026
2M ago
AAPG
Ascentage Pharma Showcases Broad Leukemia Data for Olverembatinib and Lisaftoclax at EHA2026
PremiumCompany Announcements
Ascentage Pharma Showcases Broad Leukemia Data for Olverembatinib and Lisaftoclax at EHA2026
2M ago
6855
Ascentage Pharma Trustee Buys Shares to Fund 2022 RSU Scheme
PremiumCompany Announcements
Ascentage Pharma Trustee Buys Shares to Fund 2022 RSU Scheme
2M ago
6855
Ascentage Pharma Trustee Buys Shares to Fund 2022 RSU Incentive Scheme
PremiumCompany Announcements
Ascentage Pharma Trustee Buys Shares to Fund 2022 RSU Incentive Scheme
2M ago
6855
Ascentage Pharma initiated with a Buy at B. Riley
PremiumThe Fly
Ascentage Pharma initiated with a Buy at B. Riley
2M ago
AAPG
Ascentage Pharma presents data on olverembatinib
PremiumThe FlyAscentage Pharma presents data on olverembatinib
2M ago
AAPG
Ascentage Pharma presents data from Phase 1b study of olverembatinib
Premium
The Fly
Ascentage Pharma presents data from Phase 1b study of olverembatinib
2M ago
AAPG
Ascentage Pharma presents first dataset of alrizomadlin
Premium
The Fly
Ascentage Pharma presents first dataset of alrizomadlin
2M ago
AAPG
Ascentage Pharma Trustee Buys Shares to Fund 2022 RSU Scheme
PremiumCompany Announcements
Ascentage Pharma Trustee Buys Shares to Fund 2022 RSU Scheme
2M ago
6855
Ascentage Pharma Adds 100,000 Shares to 2022 RSU Trust in Latest On‑Market Buy
PremiumCompany Announcements
Ascentage Pharma Adds 100,000 Shares to 2022 RSU Trust in Latest On‑Market Buy
2M ago
6855
Ascentage Pharma Sheds Biotech Marker After Meeting HKEX Revenue and Market Cap Tests
PremiumCompany Announcements
Ascentage Pharma Sheds Biotech Marker After Meeting HKEX Revenue and Market Cap Tests
2M ago
6855
Ascentage Pharma Showcases Promising Olverembatinib Data in Multiple Leukemia Trials at ASCO 2026
PremiumCompany Announcements
Ascentage Pharma Showcases Promising Olverembatinib Data in Multiple Leukemia Trials at ASCO 2026
2M ago
6855
Ascentage Pharma Shareholders Approve All Resolutions at 2026 AGM
PremiumCompany AnnouncementsAscentage Pharma Shareholders Approve All Resolutions at 2026 AGM
2M ago
6855
Ascentage Pharma: Buy Rating Reiterated on Advancing CML/ALL Pipeline and DCF-Supported Unchanged $48 Price Target
Premium
Ratings
Ascentage Pharma: Buy Rating Reiterated on Advancing CML/ALL Pipeline and DCF-Supported Unchanged $48 Price Target
3M ago
AAPG
Ascentage Pharma Adds Executive Equity Grants to AGM Agenda and Updates Proxy Process
Premium
Company Announcements
Ascentage Pharma Adds Executive Equity Grants to AGM Agenda and Updates Proxy Process
3M ago
6855

Trending

Name
Price
Price Change
SPX
S&P 500
―
DJIA
Dow Jones
―
NDX
Nasdaq 100
―
More Trending Stocks >